MarketFriction

KMS Medisurgi Ltd

BSE 540468 · Medical Equipment & Supplies
₹132.80 +4.98%
BSE close2026-05-13
Market cap₹43.8 Cr.
P/E175
No trades in 30 days

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales2.764.755.504.825.685.357.156.737.816.126.625.59
Expenses2.504.515.204.605.344.726.246.857.595.406.115.20
Operating Profit0.260.240.300.220.340.630.91-0.120.220.720.510.39
OPM %9.42%5.05%5.45%4.56%5.99%11.78%12.73%-1.78%2.82%11.76%7.70%6.98%
Other Income0.000.100.000.050.000.010.060.030.020.010.04-0.03
Interest0.010.020.000.000.000.000.000.020.010.080.060.05
Depreciation0.160.180.140.150.120.190.120.130.120.140.190.28
Profit before tax0.090.140.160.120.220.450.85-0.240.110.510.300.03
Tax %0.00%57.14%25.00%25.00%-18.18%28.89%28.24%-37.50%27.27%27.45%20.00%66.67%
Net Profit0.090.070.120.090.260.310.60-0.150.080.360.230.01
EPS in Rs0.270.210.360.270.790.941.82-0.450.241.090.700.03
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales8.898.417.907.329.8610.347.5110.3211.0313.8813.9412.21
Expenses8.177.596.956.859.569.687.019.7910.0713.0312.9911.28
Operating Profit0.720.820.950.470.300.660.500.530.960.850.950.93
OPM %8.10%9.75%12.03%6.42%3.04%6.38%6.66%5.14%8.70%6.12%6.81%7.62%
Other Income0.040.060.170.350.420.000.100.050.020.030.030.01
Interest0.270.240.270.190.090.070.030.000.000.020.100.14
Depreciation0.410.340.490.450.430.410.330.290.320.250.270.47
Profit before tax0.080.300.360.180.200.180.240.290.660.610.610.33
Tax %50.00%53.33%38.89%50.00%40.00%38.89%45.83%24.14%13.64%24.59%27.87%27.27%
Net Profit0.030.140.210.100.120.110.120.220.570.450.440.25
EPS in Rs0.601.170.880.300.360.330.360.671.731.361.330.76
Dividend Payout %0.00%25.71%5.71%16.50%13.75%15.00%13.75%7.50%2.89%3.67%3.75%6.60%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth4%10%3%-12%
Compounded Profit Growth6%16%-24%-43%
Stock Price CAGR%31%13%5%
Return on Equity4%5%5%3%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.501.202.403.303.303.303.303.303.303.303.303.30
Reserves0.642.131.122.852.953.053.153.373.934.364.795.01
Borrowings2.852.132.731.911.131.111.030.990.990.540.910.77
Other Liabilities3.212.602.362.143.151.641.862.171.512.651.341.47
Total Liabilities7.208.068.6110.2010.539.109.349.839.7310.8510.3410.55
Fixed Assets2.251.982.692.252.201.811.651.481.821.651.682.93
CWIP0.000.000.000.000.000.000.000.000.000.000.000.00
Investments0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets4.956.085.927.958.337.297.698.357.919.208.667.62
Total Assets7.208.068.6110.2010.539.109.349.839.7310.8510.3410.55
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity1.35-0.240.90-1.570.75-0.840.53-0.070.461.210.741.51
Cash from Investing Activity0.05-0.03-1.100.11-0.310.01-0.10-0.12-0.66-0.51-0.96-0.61
Cash from Financing Activity-1.411.131.751.57-0.81-0.06-0.11-0.02-0.01-0.470.27-0.26
Net Cash Flow-0.010.861.560.10-0.37-0.880.32-0.21-0.210.230.050.64
Free Cash Flow1.40-0.31-0.29-1.580.36-0.860.36-0.19-0.201.090.44-0.21
CFO/OP188%-18%106%-309%250%-129%108%0%59%173%96%171%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days128.10163.19185.73233.36186.94194.15305.22231.31216.42152.00111.0296.26
Inventory Days50.0217.786.2485.3482.2762.1445.4542.4570.9687.18105.11
Days Payable155.51141.02139.76134.58134.0970.42100.2758.6085.2241.1752.14
Cash Conversion Cycle22.6139.9452.21184.13135.12185.86305.22176.49200.27137.74157.03149.23
Working Capital Days21.7630.819.24158.07148.07188.85253.22200.54199.54153.84144.01142.59
ROCE %7.70%11.43%10.76%5.17%3.76%3.37%3.61%3.83%8.31%8.40%8.26%5.20%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%
Public25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.57%25.57%25.57%25.57%25.57%
No. of Shareholders575959595959596764646463

Fundamentals

Market Cap₹ 43.8 Cr.
Current Price₹ 133
Stock P/E175
Book Value₹ 25.2
ROCE5.20 %
ROE3.05 %
Dividend Yield0.04 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-12%
Compounded Profit Growth (TTM)-43%
Standalone figures.
Valuation
Market capRs 44 Cr
Enterprise valueRs 43 Cr
P/E (TTM)175.30x
Price to book5.27x
Price to sales3.59x
EV / EBITDA46.27x
EV / EBIT92.54x
EV / sales3.56x
Price to cash flow29.02x
Earnings yield0.57%
Dividend yield0.05%
P/E, 3-year average116.71x
P/B, 3-year average5.12x
P/E, 5-year average88.43x
P/B, 5-year average4.05x
Profitability
Operating margin (excl. other income)7.62%
Operating margin (incl. other income)7.70%
EBITDA margin7.70%
Pre-tax margin2.70%
Net profit margin2.05%
ROE3.05%
ROCE5.20%
ROA2.39%
ROE, 3-year average4.89%
ROCE, 3-year average7.04%
ROA, 3-year average3.64%
ROE, 5-year average5.25%
ROCE, 5-year average6.65%
ROA, 5-year average3.81%
ROIC (approx.)4.28%
Tax rate27.27%
Other income / net worth0.12%
Growth
Sales growth (latest year)-12.41%
Profit growth (latest year)-43.18%
Sales CAGR, 3 years3.45%
Sales CAGR, 5 years10.21%
Profit CAGR, 3 years-24.02%
Profit CAGR, 5 years15.81%
Per share
EPS (TTM)Rs 0.76
EPS (latest year)Rs 0.76
EPS, 3-year averageRs 1.15
EPS, 5-year averageRs 1.17
Book value per shareRs 25.18
Sales per shareRs 37.00
Cash flow per shareRs 4.58
Free cash flow per shareRs -0.64
Dividend per share (latest year)Rs 0.06
Dividend per share, 3-year averageRs 0.06
Dividend per share, 5-year averageRs 0.06
Dividends
Dividend payout8.00%
Dividend payout, 3-year average5.66%
Dividend payout, 5-year average5.92%
Efficiency
Asset turnover1.16x
Fixed asset turnover4.17x
Inventory turnover3.68x
Inventory days99 days
Debtor days96 days
Debtors turnover3.79x
Creditor days52 days
Cash conversion cycle149 days
Working capital days143 days
Leverage
Total debtRs 1 Cr
Cash and bankRs 1 Cr
Net debtRs -0 Cr
Debt to equity0.09x
Net debt / EBITDA-0.35x
Interest coverage3.36x
Owners' fund to total sources78.77%
Debt to assets7.30%
Cash flow
Cash from Operating Activity (latest year)Rs 2 Cr
Cash from Investing Activity (latest year)Rs -1 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs -0 Cr
FCFE (approx.: FCF + change in debt)Rs -0 Cr
Cash from ops / profit, 5 years1.99x
Sales to cash flow8.09x
Statement figures
Net sales (TTM)Rs 12 Cr
Net sales (latest year)Rs 12 Cr
Operating profit excl. other income (latest year)Rs 1 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 1 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 0 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Depreciation (TTM)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 9 Cr
Total expenditure (latest year)Rs 11 Cr
Total income (latest year)Rs 12 Cr
Share capitalRs 3 Cr
ReservesRs 5 Cr
Shareholders' fundsRs 8 Cr
Total assetsRs 11 Cr
Net blockRs 3 Cr
ReceivablesRs 3 Cr
InventoryRs 3 Cr
Other liabilitiesRs 1 Cr
Shares outstanding (crore)0.33
Ownership
Promoter holding74.42% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 99.6 is at the 73th percentile of its own 4.3-year range (median 94.5, low 47.1, high 135.0).
P/B 5.42 is at the 94th percentile (median 1.82).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period540468Nifty 50Difference
3 years+47.6%+14.2% +33.4 pts
5 years+289.4%+27.9% +261.6 pts

Red flags

F-score 6 of 8
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Mar 2026
Sales ₹6 Cr -16.9% vs Mar 2024. Net profit ₹0 Cr +106.7%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Poly Medicure Ltd16,67152.112.5 %
Molbio Diagnostics Ltd14,47066.618.0 %
Fischer Medical Ventures Ltd2,35596.211.4 %
Tarsons Products Ltd1,7541484.59 %
Q-Line Biotech Ltd1,56927.822.5 %
Laxmi Dental Ltd1,05830.415.0 %
Hemant Surgical Industries Ltd86951.318.9 %
Vasa Denticity Ltd75462.37.54 %
OSEL Devices Ltd69123.624.4 %
Prevest Denpro Ltd46220.524.9 %
QMS Medical Allied Services Ltd41939.012.9 %
Nureca Ltd34980.43.30 %
Aprameya Engineering Ltd20039.712.6 %
Avience Biomedicals Ltd19822.727.0 %
Earkart Limited17936.317.5 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of KMS Medisurgi Ltd?

KMS Medisurgi Ltd (540468) has a market capitalisation of Rs 43.8 Cr. at the 2026-05-13 close.

What is the P/E ratio of KMS Medisurgi Ltd?

KMS Medisurgi Ltd trades at a P/E of 175 on trailing twelve-month profit, at the 2026-05-13 close.

What were KMS Medisurgi Ltd's latest quarterly results?

In the Mar 2026 quarter, KMS Medisurgi Ltd sales was Rs 6 Cr (-16.9% vs Mar 2024) and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03